Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study (Q43048164)

From Wikidata
Jump to navigation Jump to search
scientific article published in June 2010
edit
Language Label Description Also known as
English
Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study
scientific article published in June 2010

    Statements

    Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study (English)
    Pierre Wijermans
    Martijn Schaafsma
    Fabian Termorshuizen
    Rianne Ammerlaan
    Shulamiet Wittebol
    Marinus van Marwijk Kooy
    René van der Griend
    Dutch-Belgium Cooperative Group HOVON

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit